潜江市中心医院妇科 湖北 潜江 433199
程秋瑾,女,1983—,主治医师,主要研究妇科常见疾病,E⁃mail:h7305568@163.com
收稿:2024-06-27,
纸质出版:2025-06-25
移动端阅览
程秋瑾,杨红艳,王卫兵.不同表型的多囊卵巢综合征患者的生活质量及影响因素分析[J].武汉大学学报(医学版),2025,46(06):781-786.
CHENG Qiujin,YANG Hongyan,WANG Weibing.Analysis of quality of life and influencing factors of patients with different phenotypes of polycystic ovary syndrome[J].Medical Journal of Wuhan University,2025,46(06):781-786.
程秋瑾,杨红艳,王卫兵.不同表型的多囊卵巢综合征患者的生活质量及影响因素分析[J].武汉大学学报(医学版),2025,46(06):781-786. DOI: 10.14188/j.1671-8852.2024.0478.
CHENG Qiujin,YANG Hongyan,WANG Weibing.Analysis of quality of life and influencing factors of patients with different phenotypes of polycystic ovary syndrome[J].Medical Journal of Wuhan University,2025,46(06):781-786. DOI: 10.14188/j.1671-8852.2024.0478.
目的
2
评估不同多囊卵巢综合征(PCOS)患者的生活质量(QoL)并分析其影响因素。
方法
2
采用横断面设计,将2018年1月1日—2019年12月31日88例首次诊断为PCOS并在潜江市中心医院妇产科建立记录的汉族女性纳入研究。参照鹿特丹标准进行PCOS分型,将所有患者分为26例表型A、12例表型B、22例表型C、28例表型D。使用多囊卵巢综合征健康相关生活质量问卷修正版(MPCOSQ)调查研究对象的QoL。
结果
2
人体测量指标中,不同PCOS表型研究人群的体质量存在显著差异(
P
<
0.05)。相对于表型C和表型D患者,具有表型A和B的女性表现出显著更高的胰岛素水平、胰岛素抵抗指数(HOMA⁃IR)和总睾酮(
P
<
0.05),而表型A和B之间没有观察到统计学差异。此外,4种PCOS表型的当前月经状态存在显著差异(
P
=0.036),表型A、B和D月经正常人数显著低于表型C(
P
<
0.05)。PCOS不同表型的MPCOSQ总分存在显著差异(
P
<
0.05);在多毛症亚组中,表型A和B得分显著低于表型C和D(
P
<
0.05)。在痤疮亚组中,表型A、B和C得分显著低于表型D(
P
<
0.05)。在月经症状亚组中,表型A、B和D得分显著低于表型C(
P
<
0.05)。表型A和B中较低的QoL与体质量(
β
=-0.388、-0.627,
P
<
0.001),多毛症(
β
=-0.310、-0.271,
P
<
0.01)和月经异常(
β
=-0.284、-0.305,
P
<
0.01)显著关联。表型C、D中较低的QoL与体质量(
β
=-0.437、-0.295,
P
<
0.01)和月经异常(
β
=-0.337、-0.387,
P
<
0.001)显著关联。
结论
2
表型A、B的QoL评分显著低于表型C、D。科学减肥,针对表型A和B结合抗雄激素给药并针对表型C和D提高生育能力可改善PCOS患者的生活质量。
Objective
2
To evaluate the quality of life (QoL) characteristics in women with distinct polycystic ovary syndrome (PCOS) phenotypes and explore factors related to reduced QoL.
Methods
2
A cross⁃sectional design was conducted. A total of 88 Han females were first diagnosed with PCOS and established a record at the Department of Obstetrics and Gynecology of Qianjiang Central Hospital from January 1
2018
to December 31
2019. The patients were assigned into three grouops according to the Rotterdam criteria as: 26 cases of phenotype A
12 cases of phenotype B
22 cases of phenotype C
and 28 cases of phenotype D. The QoL of the subjects was investigated using the modified polycystic ovary syndrome health⁃related quality of life questionnaire (MPCOSQ).
Results
2
Among anthropometric parameters
there were significant differences in body weight among different PCOS phenotype study populations (
P
<
0.05). Relative to the phenotype C and D patients
women with phenotypes A and B exhibited significantly higher insulin levels
HOMA⁃IR
and total testosterone (
P
<
0.05). At the same time
no difference was observed between phenotypes A and B. In addition
there was a significant difference in current menstruation status among the four PCOS phenotypes (
P
=0.036)
and the normal number of phenotypes A
B
and D was significantly lower than that of phenotype C (
P
<
0.05). The MPCOSQ total scores of different phenotypes of PCOS were significantly different (
P
<
0.05); in the hirsutism subgroup
phenotypes A and B scored patients were significantly lower than those of phenotypes C and D (
P
<
0.05). In the acne subgroup
phenotypes A
B
and C patients scored significantly lower than phenotype D patients (
P
<
0.05). In the menstrual symptom subgroup
phenotypes A
B
and D patients scored significantly lower than phenotype C patients (
P
<
0.05). Poor QoL in phenotypes A and B patients was associated with body weight (
β
=-0.388
-0.627
P
<
0.001)
hirsutism (
β
=-0.310
-0.271
P
<
0.01) and menstrual abnormalities (
β
=-0.284
-0.305
P
<
0.01). Poor QoL in phenotypes C and D patients was significantly associated with body weight (
β
=-0.437
-0.295
P
<
0.01) and menstrual abnorma
lities (
β
=-0.337
-0.387
P
<
0.001).
Conclusion
2
The QoL scores of phenotypes A and B patients were significantly lower than those of phenotypes C and D. Interventions to improve QoL in PCOS patients are scientific weight loss and combined antiandrogen administration for phenotypes A and B
and enhancing fertility for phenotypes C and D.
韩启新 , 徐洁颖 , 储维薇 , 等 . 雄激素与肠道菌群在多囊卵巢综合征中作用机制的研究进展 [J ] . 生理科学进展 , 2020 , 51 ( 1 ): 77 ‑ 81 .
HAN Q X , XU J Y , CHU W W , et al . Role of androgen and gastrointestinal microbiome in the polycystic ovary syndrome [J ] . Prog Physiol Sci , 2020 , 51 ( 1 ): 77 ‑ 81 .
寇丽辉 , 侯丽辉 , 马建 , 等 . 多囊卵巢综合征(痰湿证)合并胰岛素抵抗患者的临床特征分析 [J ] . 中华中医药杂志 , 2020 , 35 ( 4 ): 2113 ‑ 2116 .
KOU L H , HOU L H , MA J , et al . Clinical characteristics of patients with polycystic ovary syndrome (phlegm‑dampness syndrome) combined with insulin resistance [J ] . China J Tradit Chin Med Pharm , 2020 , 35 ( 4 ): 2113 ‑ 2116 .
乔杰 , 齐新宇 , 徐雅兰 , 等 . 关注影响女性健康的重要生殖内分泌疾病多囊卵巢综合征 [J ] . 中国实用妇科与产科杂志 , 2020 , 36 ( 1 ): 1 ‑ 9 .
QIAO J , QI X Y , XU Y L , et al . Pay attention to polycystic ovary syndrome, an important reproductive endocrine disease affecting women's health [J ] . Chin J Pract Gynecol Obstet , 2020 , 36 ( 1 ): 1 ‑ 9 .
钟兴明 , 顾恒 , 苗竹林 , 等 . PCOS不同临床表型的关系分析 [J ] . 中国妇幼健康研究 , 2020 , 31 ( 10 ): 1400 ‑ 1404 .
ZHONG X M , GU H , MIAO Z L , et al . The correlation research between the clinical features of PCOS [J ] . Chin J Woman Child Health Res , 2020 , 31 ( 10 ): 1400 ‑ 1404 .
RIESTENBERG C , JAGASIA A , MARKOVIC D , et al . Health care‑related economic burden of polycystic ovary syndrome in the United States: Pregnancy‑related and long‑term health consequences [J ] . J Clin Endocrinol Metab , 2022 , 107 ( 2 ): 575 ‑ 585 .
赵晓苗 , 杨亚波 , 韩杨 , 等 . 改良简化的Ferriman⁃Gallwey评分系统在中国女性多毛评价中的应用分析 [J ] . 中山大学学报(医学科学版) , 2017 , 38 ( 5 ): 699 ⁃ 704 .
ZHAO X M , YANG Y B , HAN Y , et al . Simplified analysis of modified Ferriman⁃Gallwey scoring system in evaluation of Chinese women: A prospective follow⁃up study in new terminal hair among pregnant women [J ] . J Sun Yat Sen Univ Med Sci , 2017 , 38 ( 5 ): 699 ⁃ 704 .
中国痤疮治疗指南专家组 . 中国痤疮治疗指南(2019修订版) [J ] . 临床皮肤科杂志 , 2019 , 48 ( 9 ): 583 ‑ 588 .
China Acne Treatment Guidelines Expert Group . Guideline for diagnosis and treatment of acne(the 2019 revised edition) [J ] . China Ind Econ , 2019 , 48 ( 9 ): 583 ‑ 588 .
DAI H , ALSALHE T A , CHALGHAF N , et al . The global burden of disease attributable to high body mass index in 195 countries and territories, 1990‑2017: An analysis of the Global Burden of Disease Study [J ] . PLoS Med , 2020 , 17 ( 7 ): e1003198 .
NI C M , HUANG W L , JIANG Y M , et al . Improving the accuracy and efficacy of diagnosing polycystic ovary syndrome by integrating metabolomics with clinical characteristics: Study protocol for a randomized controlled trial [J ] . Trials , 2020 , 21 ( 1 ): 169 .
LUO Y Y , XU X L , LI X B . Psychometric properties of the Chinese version of the modified polycystic ovary syndrome health‑related quality‑of‑life questionnaire [J ] . Health Qual Life Outcomes , 2020 , 18 ( 1 ): 131 .
BERNI T R , MORGAN C L , BERNI E R , et al . Polycystic ovary syndrome is associated with adverse mental health and neurodevelopmental outcomes [J ] . J Clin Endocrinol Metab , 2018 , 103 ( 6 ): 2116 ‑ 2125 .
DE FREITAS FONSECA M , ARAGAO L C , SESSA F V , et al . Interrelationships among endometriosis‑related pain symptoms and their effects on health‑related quality of life: A sectional observational study [J ] . Obstet Gynecol Sci , 2018 , 61 ( 5 ): 605 ‑ 614 .
周玲 , 俞超芹 , 翟东霞 , 等 . 不同体质量指数多囊卵巢综合征患者临床及内分泌特征的对比观察 [J ] . 中华中医药杂志 , 2020 , 35 ( 6 ): 3240 ‑ 3242 .
ZHOU L , YU C Q , ZHAI D X , et al . Comparative observation of clinical and endocrine characteristics of patients with polycystic ovary syndrome with different body mass indexes [J ] . China J Tradit Chin Med Pharm , 2020 , 35 ( 6 ): 3240 ‑ 3242 .
王东旭 , 石文婧 , 徐樱溪 , 等 . 肥胖多囊卵巢综合征患者转氨酶升高的影响因素研究 [J ] . 中国全科医学 , 2022 , 25 ( 3 ): 320 ‑ 324 .
WANG D X , SHI W J , XU Y X , et al . Associated factors of elevated transaminase in obese patients with polycystic ovary syndrome [J ] . Chin Gen Pract , 2022 , 25 ( 3 ): 320 ‑ 324 .
SÁNCHEZ‑FERRER M L , ADOAMNEI E , PRIETO‑SÁNCHEZ M T , et al . Health‑related quality of life in women with polycystic ovary syndrome attending to a tertiary hospital in Southeastern Spain: A case‑control study [J ] . Health Qual Life Outcomes , 2020 , 18 ( 1 ): 232 .
KRENTOWSKA A , KOWALSKA I . Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome [J ] . Diabetes Metab Res Rev , 2022 , 38 ( 1 ): e3464 .
KAZEMI M , MCBREAIRTY L E , ZELLO G A , et al . A pulse‑based diet and the Therapeutic Lifestyle Changes diet in combination with health counseling and exercise improve health‑related quality of life in women with polycystic ovary syndrome: Secondary analysis of a randomized controlled trial [J ] . J Psychosom Obstet Gynaecol , 2020 , 41 ( 2 ): 144 ‑ 153 .
COONEY L G , MILMAN L W , HANTSOO L , et al . Cognitive‑behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: A pilot randomized clinical trial [J ] . Fertil Steril , 2018 , 110 ( 1 ): 161 ‑ 171.e1 .
0
浏览量
7
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621